Skip to main content

Table 1 Main Demographic and clinical characteristics in 95 RA patients

From: The impact of rheumatoid foot on disability in Colombian patients with rheumatoid arthritis

Variables Percentage
Female 83.1% (79)
RF (+) 70.1% (63/89)
Steroid therapy 72.6% (69)
Methotrexate 80% (76)
Chloroquine 63.1% (60)
DMARDS 35.7% (34)
Tumor necrosis factor alpha inhibitor 15.8% (15)
  Mean ± SD
Current Age (years) 52.5 ± 12.4
Age at RA onset (years) 44 ± 12.4
Duration of RA (years) 9 ± 7.1
Swollen joints count 4.9 ± 5.6
Patient global assessment (VAS) 4.2 ± 2.7
Physician global assessment (VAS) 4.5 ± 2.3
HAQ 0.5 ± 0.6
DAS 28 3.7 ± 1.5
ESR (mm/hour) 30.6 ± 21.1
CRP (mg/dl) 0.9 ± 1.1
  1. RF: rheumatoid factor (IU/ml); HAQ: Health Assessment Questionnaire; DAS 28: Disease Activity Score 28; ESR: erythrocyte sedimentation rate; CRP: C reactive protein; VAS: Visual Analogue Scale; DMARDS: Disease Modifying antirheumatic drugs